Sex and dependence related neuroanatomical differences in regular cannabis users: findings from the ENIGMA Addiction Working Group.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
06 05 2021
Historique:
received: 02 12 2020
accepted: 09 04 2021
revised: 25 03 2021
entrez: 7 5 2021
pubmed: 8 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Males and females show different patterns of cannabis use and related psychosocial outcomes. However, the neuroanatomical substrates underlying such differences are poorly understood. The aim of this study was to map sex differences in the neurobiology (as indexed by brain volumes) of dependent and recreational cannabis use. We compared the volume of a priori regions of interest (i.e., amygdala, hippocampus, nucleus accumbens, insula, orbitofrontal cortex (OFC), anterior cingulate cortex and cerebellum) between 129 regular cannabis users (of whom 70 were recreational users and 59 cannabis dependent) and 114 controls recruited from the ENIGMA Addiction Working Group, accounting for intracranial volume, age, IQ, and alcohol and tobacco use. Dependent cannabis users, particularly females, had (marginally significant) smaller volumes of the lateral OFC and cerebellar white matter than recreational users and controls. In dependent (but not recreational) cannabis users, there was a significant association between female sex and smaller volumes of the cerebellar white matter and OFC. Volume of the OFC was also predicted by monthly standard drinks. No significant effects emerged the other brain regions of interest. Our findings warrant future multimodal studies that examine if sex and cannabis dependence are specific key drivers of neurobiological alterations in cannabis users. This, in turn, could help to identify neural pathways specifically involved in vulnerable cannabis users (e.g., females with cannabis dependence) and inform individually tailored neurobiological targets for treatment.

Identifiants

pubmed: 33958576
doi: 10.1038/s41398-021-01382-y
pii: 10.1038/s41398-021-01382-y
pmc: PMC8102553
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

272

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA047119
Pays : United States

Références

Neuropsychopharmacology. 2012 Oct;37(11):2368-76
pubmed: 22669173
Hum Brain Mapp. 2014 Apr;35(4):1654-67
pubmed: 23616424
Neuropsychopharmacology. 2014 Aug;39(9):2041-8
pubmed: 24633558
Mol Psychiatry. 2012 Jun;17(6):642-9
pubmed: 21747398
Psychiatry Res. 2010 May 30;182(2):152-9
pubmed: 20413277
Drug Alcohol Depend. 2019 Jan 1;194:20-27
pubmed: 30391834
Curr Addict Rep. 2016;3:323-331
pubmed: 27525213
Addict Biol. 2020 Nov;25(6):e12839
pubmed: 31814242
Toxicol Appl Pharmacol. 2008 Apr 1;228(1):8-16
pubmed: 18083204
Drug Alcohol Depend. 2013 Jun 1;130(1-3):101-8
pubmed: 23182839
J Subst Abuse Treat. 2016 Jul;66:16-22
pubmed: 27211992
Addict Biol. 2014 Jul;19(4):722-32
pubmed: 23311613
Brain Imaging Behav. 2020 Oct;14(5):1588-1599
pubmed: 31197582
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):59-71
pubmed: 30706169
Addict Biol. 2019 Nov;24(6):1121-1137
pubmed: 30811097
Psychol Med. 2011 Nov;41(11):2349-59
pubmed: 21466751
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt A):85-107
pubmed: 29355587
Psychol Addict Behav. 2013 Jun;27(2):431-42
pubmed: 22564204
Nat Neurosci. 2014 Apr;17(4):491-6
pubmed: 24671065
Addiction. 1995 May;90(5):607-14
pubmed: 7795497
Handb Clin Neurol. 2014;125:ix-x
pubmed: 25307604
Addict Behav. 2010 Feb;35(2):102-10
pubmed: 19818563
Biol Psychiatry. 2012 Apr 15;71(8):684-92
pubmed: 22129756
J Neurosci. 2002 Nov 15;22(22):9742-53
pubmed: 12427829
Exp Clin Psychopharmacol. 2015 Dec;23(6):415-21
pubmed: 26461168
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Life Sci. 2013 Mar 19;92(8-9):476-81
pubmed: 22728714
Neurosci Biobehav Rev. 2016 Jan;60:1-11
pubmed: 26602022
J Clin Invest. 2013 Jul;123(7):2816-31
pubmed: 23934130
Addict Biol. 2009 Sep;14(4):457-68
pubmed: 19650817
Arch Gen Psychiatry. 2008 Jun;65(6):694-701
pubmed: 18519827
Neuroscience. 1997 Mar;77(2):299-318
pubmed: 9472392
Transl Psychiatry. 2016 Jan 12;6:e710
pubmed: 26756903
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Cereb Cortex. 2018 Aug 1;28(8):2959-2975
pubmed: 29771288
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Neuropsychol Rev. 2013 Jun;23(2):117-37
pubmed: 23129391
Drug Alcohol Depend. 2004 Jun 11;74(3):265-72
pubmed: 15194204
J Neurosci. 2014 Apr 16;34(16):5529-38
pubmed: 24741043
Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
pubmed: 22011681
Exp Clin Psychopharmacol. 2015 Aug;23(4):238-46
pubmed: 26237321
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Front Psychiatry. 2014 Jan 29;5:8
pubmed: 24523702
Biol Psychiatry. 2016 Apr 1;79(7):e17-31
pubmed: 26858212
Psychopharmacology (Berl). 2017 Jul;234(13):1985-1995
pubmed: 28364340
Aust N Z J Psychiatry. 2020 Jan;54(1):68-75
pubmed: 31298035
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Drug Alcohol Depend. 2018 Apr 1;185:23-32
pubmed: 29413435
Synapse. 1997 Jul;26(3):317-23
pubmed: 9183820
Neuropsychopharmacology. 2016 Jun;41(7):1716-23
pubmed: 26576924
Psychiatry Res Neuroimaging. 2016 Sep 30;255:24-34
pubmed: 27500453
Drug Alcohol Depend. 2017 Apr 01;173:92-98
pubmed: 28212516
Front Psychiatry. 2018 May 03;9:175
pubmed: 29773998
Neurosci Biobehav Rev. 2014 Feb;39:34-50
pubmed: 24374381
J Neurosci. 2015 Jan 28;35(4):1505-12
pubmed: 25632127
Behav Brain Res. 2011 Oct 10;224(1):128-34
pubmed: 21664935
Dev Cogn Neurosci. 2015 Dec;16:101-109
pubmed: 25953106
Exp Clin Psychopharmacol. 2015 Aug;23(4):206-16
pubmed: 26237318
Psychopharmacology (Berl). 2017 Jul;234(14):2149-2157
pubmed: 28424833
Int J Neuropsychopharmacol. 2015 Jun 04;18(10):pyv061
pubmed: 26045474
Neuroimage. 2012 Feb 15;59(4):3845-51
pubmed: 21982932
Brain Struct Funct. 2018 Sep;223(7):3317-3326
pubmed: 29882015
Nat Neurosci. 2005 Nov;8(11):1481-9
pubmed: 16251991
Br J Pharmacol. 2010 Jun;160(3):544-8
pubmed: 20590564
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Psychopharmacology (Berl). 2015 Aug;232(16):2939-50
pubmed: 25921032
Addict Biol. 2014 May;19(3):317-31
pubmed: 24851284
Perspect Psychol Sci. 2013 Jan;8(1):3-24
pubmed: 26069472
Am J Psychiatry. 2019 Feb 1;176(2):119-128
pubmed: 30336705
PLoS One. 2012;7(6):e38272
pubmed: 22701619
Can J Psychiatry. 2019 May;64(5):345-350
pubmed: 30260680
Neuroimage. 2004 Jul;22(3):1060-75
pubmed: 15219578

Auteurs

Maria Gloria Rossetti (MG)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Scott Mackey (S)

Department of Psychiatry, University of Vermont, Burlington, VT, USA.

Praveetha Patalay (P)

Centre for Longitudinal Studies and MRC Unit for Lifelong Health and Ageing, IOE and Population Health Sciences, UCL, London, UK.

Nicholas B Allen (NB)

Department of Psychology, University of Oregon, Eugene, OR, USA.

Albert Batalla (A)

Department of Psychiatry, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.

Marcella Bellani (M)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Yann Chye (Y)

BrainPark, Turner Institute for Brain and Mental Health, School of Psychological Sciences & Monash Biomedical Imaging Facility, Monash University, Melbourne, VIC, Australia.

Patricia Conrod (P)

Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada.

Janna Cousijn (J)

Department of Developmental Psychology, University of Amsterdam, Amsterdam, the Netherlands.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont, Burlington, VT, USA.

Anna E Goudriaan (AE)

Department of Psychiatry, Amsterdam Institute for Addiction Research, University of Amsterdam, Amsterdam, Netherlands.

Robert Hester (R)

School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia.

Rocio Martin-Santos (R)

Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM and Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Nadia Solowij (N)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Chao Suo (C)

BrainPark, Turner Institute for Brain and Mental Health, School of Psychological Sciences & Monash Biomedical Imaging Facility, Monash University, Melbourne, VIC, Australia.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Murat Yücel (M)

BrainPark, Turner Institute for Brain and Mental Health, School of Psychological Sciences & Monash Biomedical Imaging Facility, Monash University, Melbourne, VIC, Australia.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Valentina Lorenzetti (V)

Neuroscience of Addiction & Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural & Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, VIC, Australia. valentina.lorenzetti@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH